Announce Date | 08/11/2025 |
EPS Normalized Actual | $0.05 (Beat by $0.04) |
EPS GAAP Actual | $0.05 (Beat by $0.04) |
Revenue Actual | $0.091339B |
Revenue Surprise | Beat by $91.339M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $-0.03 |
EPS GAAP Estimate | $-0.03 |
Revenue Estimate | $0.151B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 0.14 | 23.07 | 0.13318 | 0.14682 | 1 |
Dec 2028 | 0.03 | 107.67 | 0.02595624 | 0.03534023 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | -0.33 | -0.435 | 0.091339B | 8.39% | -153.42M |
FQ1 2025 (Mar 2025) | 0.19 | 0.19 | 0.116491B | 30.17% | 116.49M |
FQ4 2024 (Dec 2024) | -0.26 | -0.26 | 0.113387B | 7.77% | 113.39M |
FQ3 2024 (Sep 2024) | 0.0413 | 0.0413 | 0.101388B | 20.98% | 101.39M |
FQ2 2024 (Jun 2024) | -0.25 | -0.25 | 0.083675B | 10.42% | 83.68M |
FQ1 2024 (Mar 2024) | -0.0787 | -0.0787 | 0.081351B | 42.26% | 81.35M |
FQ4 2023 (Dec 2023) | -0.0779 | -0.0779 | 0.104575B | -58.62% | 104.58M |
FQ3 2023 (Sep 2023) | -0.0835 | -0.0835 | 0.080116B | 51.8% | 80.12M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
-0.03
Consensus Revenue Estimates
0.151B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.09 | -- | 0.08922305 | 0.09077695 | 1 |
FQ3 2027 (Sep 2027) | 0.09 | -- | 0.0880446 | 0.09298604 | 1 |
FQ2 2027 (Jun 2027) | 0.09 | -- | 0.0880446 | 0.09298604 | 1 |
FQ1 2027 (Mar 2027) | 0.09 | -- | 0.08922305 | 0.09077695 | 1 |
FQ4 2026 (Oct 2026) | 0.07 | -- | 0.06396852 | 0.07603148 | 0 |
FQ3 2026 (Jul 2026) | 0.07 | -- | 0.06396852 | 0.07603148 | 0 |
FQ2 2026 (Jun 2026) | 0.31 | 206.45 | 0.25953 | 0.39855 | 0 |
FQ1 2026 (Mar 2026) | 0.3 | 36.67 | 0.25116 | 0.3857 | 0 |
FQ4 2025 (Oct 2025) | -0.01 | -2500 | -0.01086164 | -0.00913836 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.21B | -- | 0.21B | 0.21B | 1 |
FQ3 2027 (Sep 2027) | 0.21B | -- | 0.21B | 0.22B | 2 |
FQ2 2027 (Jun 2027) | 0.21B | -- | 0.2B | 0.21B | 2 |
FQ1 2027 (Mar 2027) | 0.19B | -- | 0.19B | 0.19B | 1 |
FQ4 2026 (Oct 2026) | 0.23B | -- | 0.21B | 0.24B | 1 |
FQ3 2026 (Jul 2026) | 0.22B | -- | 0.21B | 0.24B | 1 |
FQ2 2026 (Jun 2026) | 0.39B | 76.76 | 0.34B | 0.48B | 1 |
FQ1 2026 (Mar 2026) | 0.39B | 69.98 | 0.34B | 0.47B | 1 |
FQ4 2025 (Oct 2025) | 0.16B | 29.57 | 0.15B | 0.17B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
6
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.105 | -0.33 | -0.435 | 131.82% |
FQ1 2025 (Mar 2025) | 0.19 | 0.19 | 100% | |
FQ4 2024 (Dec 2024) | -0.26 | -0.26 | 100% | |
FQ3 2024 (Sep 2024) | 0.0413 | 0.0413 | 100% | |
FQ2 2024 (Jun 2024) | -0.25 | -0.25 | 100% | |
FQ1 2024 (Mar 2024) | -0.0787 | -0.0787 | 100% | |
FQ4 2023 (Dec 2023) | -0.0779 | -0.0779 | 100% | |
FQ3 2023 (Sep 2023) | -0.0835 | -0.0835 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0.24B | $0.09B | $-153.42M | -167.96% |
FQ1 2025 (Mar 2025) | $0B | $0.12B | $116.49M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.11B | $113.39M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.1B | $101.39M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.08B | $83.68M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0.08B | $81.35M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0.1B | $104.58M | 100% |
FQ3 2023 (Sep 2023) | $0B | $0.08B | $80.12M | 100% |